Research Launchpad

Intravenous indomethacin more effective for hsPDAs

Le Bonheur researchers begin multiple COVID-19 investigation efforts

Interventional cardiologist publishes guidance for catheterization labs, conservation of resources

Le Bonheur researchers develop method for re-use of N95 respirators using dry heat kilns

Renowned rheumatologist and immunologist brings expertise in research, collaboration to Le Bonheur Children’s

Towbin receives National Institutes of Health Research Project Grant to study genetic causes of cardiomypathy.

Goasain receives $2 million from National Institutes of Health to study Hirschsprung-Associated Enterocolitis causes.

Eosinophils residing in the airways of mice respond to influenza A virus (IAV) infection through alterations in surface expression of various markers necessary for migration and cellular immunity responses, according to Le Bonheur research published in the Journal of Leukocyte Biology.

In carefully selected patients, ETV is a durable treatment for many patients, and neurosurgeons need to train or retrain their way of thinking when seeing a shunt malfunction by always asking ‘Is this patient a candidate for an ETV?'

One family’s journey with drug trials for Dravet syndrome

The onset of the COVID-19 pandemic forced health care institutions to change the way they deliver care and innovate new ways to meet the unusual demands created in a space of social distancing, masks and PPE shortages.

The latest news from Le Bonheur Children's